South China Venture Capital
39
26M
36
2.44
7
0.08
- Stages of investment
- Areas of investment
Summary
In 2008 was created South China Venture Capital, which is appeared as VC. The main office of represented VC is situated in the Shenzhen. The fund was located in Asia if to be more exact in China.
The top activity for fund was in 2019. The fund is constantly included in 2-6 investment rounds annually. Considering the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations. The usual things for fund are deals in the range of 50 - 100 millions dollars.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the South China Venture Capital, startups are often financed by Trend Investment Group, Oriza Seed Capital (Oriza Yuandian), OrbiMed. The meaningful sponsors for the fund in investment in the same round are Sherpa Venture Capital, Shenzhen Capital Group, SDIC Fund Management.
The fund has exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Apollomics, EpimAb Biotherapeutics, Ipoweru.cn. We can highlight the next thriving fund investment areas, such as Training, Health Care. For fund there is a match between the location of its establishment and the land of its numerous investments - China. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.
Investments analytics
Analytics
- Total investments
- 39
- Lead investments
- 7
- Rounds per year
- 2.44
- Follow on index
- 0.08
- Investments by industry
- Health Care (11)
- Manufacturing (10)
- Biotechnology (9)
- Pharmaceutical (7)
- Semiconductor (7) Show 41 more
- Investments by region
-
- China (34)
- United States (3)
- Peak activity year
- 2023
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Group Appearance index
- 0.87
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Huixin Bio | 19 Jan 2023 | Biotechnology, Pharmaceutical, Biopharma | Seed | Shenzhen, Guangdong, China | |
| Presheng | 03 Jun 2024 | Manufacturing, Semiconductor | Seed | 1M |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.